Here, we provide compelling evidence that the high expression of the UGT2B17 protein enhances the BCR-signaling capacity in B-CLL cells and promotes proliferation through functional interplay with several BCR effectors, including BTK, and with other activating signaling pathways, such as those triggered by cytokines. Here, BCR is linked to B-cell chronic lymphocytic leukemia.